Masculinization of the external genitalia in humans is dependent on formation of 5α-3 dihydrotestosterone (DHT) through both the canonical androgenic pathway and an alternative 4 (backdoor) pathway. The fetal testes are essential for canonical androgen production but little 5 is known about the synthesis of backdoor androgens despite their known critical role in 6 masculinization. In this study, we have measured plasma and tissue levels of endogenous 7 steroids in second trimester human male fetuses using multi-dimensional and high-resolution 8 mass-spectrometry. Results show that androsterone is the principal backdoor androgen in the 9 fetal circulation and that DHT is undetectable (<1ng/ml). Backdoor pathway intermediates 10 are found primarily in the placenta and fetal liver with significant androsterone levels also in 11 the fetal adrenal. Backdoor intermediates, including androsterone, are mostly undetectable in 12 the fetal testes. This is consistent with transcript levels of enzymes involved in the backdoor 13 pathway (SRD5A1, AKR1C2/4, CYP17A1), as measured by qPCR. These data identify 14 androsterone as the predominant backdoor androgen in the human fetus and show that it is 15 formed primarily in non-gonadal tissue with placental progesterone the likely substrate. 16 Masculinization of the human fetus depends, therefore, on androgen synthesis by both the 17 fetal testes and non-gonadal tissues leading to DHT formation at the genital tubercle. Our 18 findings provide, for the first time, a solid basis to explain why placental insufficiency is 19 associated with disorders of sex development in humans 20 29 tubercle/penis begins around 10-12 weeks of gestation (4;5) and continues through the second 30 and third trimesters (6;7). The etiology of hypospadias is probably multifactorial but it is 31 likely that altered androgen exposure during the second trimester is a significant factor (8). 32 During masculinization testosterone acts directly to stabilize the mesonephric 33 (Wolffian) ducts and to induce testis descent. However, it is conversion of testosterone to the 34 more potent 5α-dihydrotestosterone (DHT) at the target organ which leads to masculinization 35 of the external genitalia (9). In humans, testosterone is synthesized in the testicular Leydig 36 cells through the canonical Δ 5 pathway shown in Fig 1 (10;11 ). More recently, however, it 37 has been reported that an alternative pathway to DHT formation exists which does not require 38 testosterone as an intermediate. This alternative, "backdoor", pathway ( Fig 1) was first 39 described in the testes of pouch young marsupials (12) and a similar pathway has since been 40 reported in the prepubertal mouse testis (13) and the fetal human testis (14). The importance 41 of the backdoor pathway to normal human development was initially unclear, but studies by 42 Fluck et al (14) have shown that disordered sex development (DSD) will arise if the pathway 43
Introduction

22
The male external genitalia are the most common site of congenital abnormalities in the 23 human, with up to 0.8% of male births affected (1;2). The most frequent of these 24 abnormalities is hypospadias, which is characterized by abnormal opening of the urethra on 25 the ventral side of the penis. Normal masculinization of the fetus is dependent upon androgen 26 secretion by the testis and androgens act initially during a critical masculinization 27 programming window to ensure normal male reproductive development (3). In humans, 28 male-specific morphological differentiation and subsequent growth of the genital taking tissue mass into account, liver and placenta each have ~200 times more total AKR1C2 144 transcript than the fetal testes. There was also significant AKR1C2 expression in the genital 145 tubercle which is likely to be important for local DHT synthesis from androsterone (Fig 1) . 146 AKR1C4 is the other backdoor enzyme which may be required for masculinization (14) and 147 transcripts were only consistently detected in the fetal liver (Fig 4) . Expression of HSD17B6 148 was highest in the testis with transcripts also consistently detected in the adrenal and placenta 149 and lower expression in the genital tubercle (Fig 4) . HSD17B3 was expressed at similar levels 150 in the testis and liver, with very low or undetectable expression in the placenta, adrenal and 151 genital tubercle (Fig 4) . AKR1C3 showed the highest level of expression in the liver with low 152 but detectable expression in other tissues. The cytochrome P450 enzyme CYP17A1 is 153 essential in both canonical and backdoor pathways of androgen synthesis (Fig 1) . Predictably, 154 expression was high in both fetal adrenal and fetal testis, with the mean adrenal level about 6 155 times that of the testis (Fig 4) . Expression was very low or undetectable in the genital 156 tubercle, liver and placenta. The HSD3B2 enzyme is essential for de novo androgen synthesis pathway to DHT synthesis is also required for normal human fetal male development (14) has 169 shown that the process is a complex interaction between different steroidogenic pathways. In 170 this study we now show for the first time that androsterone is the major circulating backdoor 171 androgen in the human male fetus and that most circulating androsterone comes from non-172 gonadal tissues that use placental progesterone (or its metabolites) as substrate.
173
Masculinization depends, therefore, not only on the fetal testes, but also on other, non-174 gonadal tissues.
175
The backdoor pathway of androgen synthesis depends, initially, on progesterone 176 formed from pregnenolone and in the fetus the major de novo sources of pregnenolone are the 177 adrenal and the testis. In both tissues, however, pregnenolone is metabolized predominantly 178 through the Δ 5 pathway to DHEA because pregnenolone is bound with a significantly higher 179 affinity by human CYP17A1 than by HSD3B2 (21). In addition, HSD3B activity is likely to 180 be relatively low compared to CYP17A1 in both tissues, based on transcript levels (this study 181 and (22;23)). Both tissues contain progesterone, at levels similar to those reported previously 182 (24), but the tissue concentrations, particularly in the testis, are not markedly greater than 183 those in the liver which lacks significant HSD3B expression and does not have the capacity to 184 synthesize progesterone de novo (25). This means that most progesterone in fetal human 185 tissues and circulation is likely to come from the placenta which has been shown previously 186 to secrete progesterone directly into the fetal circulation at high levels (26;27), similar to 187 those reported here.
188
Metabolism of progesterone to 5αDHP depends on SRD5A1 and transcript levels of 189 this enzyme are highest in the liver, with lower levels also present in the placenta and testis. likely to be the major sites of 5αDHP and allopregnanolone production in the second 208 trimester fetus. Placental allopregnanolone production would also be consistent with the 209 increasing plasma levels in pregnant women during gestation (29). Finally, it should be noted 210 that 50% or more of any steroids secreted into the fetal circulation by the placenta will go 211 directly to the fetal liver through the umbilical vein and so most fetal 5α-reduction or 3α-212 hydroxylation of placental progesterone is likely to take place in the fetal liver.
213
Once formed, there is a high affinity between allopregnanolone and human CYP17A1
show 46,XX virilization. It is likely that virilization in these individuals in utero is due to 269 excessive backdoor androgen synthesis which is occurring in the absence of testes (38-40). It 270 has been postulated that this increase in fetal backdoor androgen production comes from the 271 fetal adrenals (41;42). The lack of SRD5A1 and intermediates in the backdoor pathway in 272 normal fetal adrenals make this unlikely, however, unless the condition itself increases shown that maternal hCG levels tend to be increased in placental insufficiency (43). In 286 contrast, maternal progesterone levels are reported to be reduced during IUGR (45), 287 suggesting placental steroidogenesis is affected. If the placenta is central to fetal backdoor 288 androgen production, as we suggest, then altered placental steroidogenesis may lead directly 289 to abnormalities in masculinization.
290
Studies in the 1950s/60s by Jost and others showed that androgen is required for 291 masculinization of the external genitalia (reviewed in (46)). Later studies showed that 292 testicular testosterone must be converted to DHT at the target organ to induce masculinization (47). Most recently, it has been shown that the normal process of 294 masculinization in the human depends on two separate pathways of androgen synthesis, the 295 canonical and backdoor pathways (14) . We now report that the backdoor pathway in the 296 human fetus is driven by placental progesterone production which acts as substrate for 297 androsterone synthesis, primarily in non-gonadal tissues. This means that our current 298 understanding of the endocrine control of masculinization in the human fetus is that it is 299 mediated through circulating testosterone and androsterone and is dependent on a complex 300 interaction and exchange between the testes and non-gonadal tissues, particularly the 301 placenta. 
